Arcturus Therapeutics Ltd (NASDAQ:ARCT)

5.66
Delayed Data
As of 1:20pm ET
 +0.119 / +2.15%
Today’s Change
4.78
Today|||52-Week Range
15.19
-28.82%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$59.2M

Company Description

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of RNA medicines using proprietary lipid-mediated delivery system (LUNAR) and UNA Oligomer chemistry technologies. The company was founded in March 2013 and is headquartered in San Diego, CA.

Contact Information

Arcturus Therapeutics Ltd.
10628 Science Center Drive
San Diego California 92121
P:(858) 900-2660
Investor Relations:

Employees

Shareholders

Mutual fund holders9.24%
Other institutional0.14%
Individual stakeholders--

Top Executives

Mark R. HerbertPresident
Christine EsauVice President-Research & Development